Results 41 to 50 of about 92,350 (272)

Histological Assessment of Respiratory Tract and Liver of BALB/c Mice Nebulized with Tocilizumab [PDF]

open access: yes
Pulmonary drug delivery offers a minimally invasive and efficient method for treating lung conditions, leveraging the lungs’ extensive surface area and blood flow for rapid drug absorption.
Henriquez-Camacho, César   +4 more
core   +2 more sources

Successful Tocilizumab Treatment for Scleritis [PDF]

open access: yes, 2019
Purpose: To present a rare case of scleritis associated with a prior diagnosis of giant cell arteritis (GCA) that was unresponsive to glucocorticoids, nonsteroidal anti-inflammatory drugs (NSAIDs), methotrexate, and azathioprine, but reached and ...
Rothova, Aniki   +8 more
core   +1 more source

Case Report: Safety and Efficacy of Tocilizumab in a Patient with Rheumatoid Arthritis and Chronic Hepatitis C

open access: yesCase Reports in Medicine, 2012
Tocilizumab is a monoclonal humanized anti-IL-6-receptor antibody used for the treatment of rheumatoid arthritis. The safety of tocilizumab in HCV patients is an open question. We report on safety and efficacy of tocilizumab in a 71-year-old female with
Filippo Iebba   +5 more
doaj   +1 more source

Tocilizumab in Coronavirus Disease 2019-Related Critical Illness: A Propensity Matched Analysis

open access: yesCritical Care Explorations, 2021
Objectives:. The primary objective was to evaluate ICU mortality at 28 days in patients with severe hypoxemic respiratory failure due to coronavirus disease 2019 infection who received tocilizumab. The secondary objectives were to evaluate ICU-, hospital-
Prabalini Rajendram, MD   +6 more
doaj   +1 more source

Herpes Zoster After Tocilizumab Therapy in COVID-19 Survivor: A Case Report

open access: yesActa Medica Indonesiana, 2022
The COVID-19 pandemic has become a concern for the world community. However, despite abundant attempts taking place, there is currently no definitive therapy for COVID-19 yet.
Suwenny Suwenny, Sahat Halim
doaj   +2 more sources

Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up

open access: yesEClinicalMedicine, 2020
Background: Pneumonia with severe respiratory failure represents the principal cause of death in COVID-19, where hyper-inflammation plays an important role in lung damage.
Nicola De Rossi   +18 more
doaj   +1 more source

Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis

open access: yesInfectious Diseases of Poverty, 2021
Background Coronavirus disease 2019 (COVID-19) has killed over 2.5 million people worldwide, but effective care and therapy have yet to be discovered. We conducted this analysis to better understand tocilizumab treatment for COVID-19 patients.
Qiu Wei   +6 more
doaj   +1 more source

Intestinal disease secondary to tocilizumab.

open access: yes, 2022
20.500.12530/87913It is presented a case study of intestinal affectation on a patient under tocilizumab treatment for giant cell ...
Suárez-Ferrer, Cristina   +2 more
core   +1 more source

Tocilizumab promotes corneal allograft survival in rats by modulating Treg-Th17 balance [PDF]

open access: yesInternational Journal of Ophthalmology, 2019
AIM: To examine the therapeutic effects of tocilizumab on experimental corneal transplantation and its effect on Treg/Th17 balance. METHODS: Allograft corneal graft was performed between host Sprague Dawley and Wistar donor rats.
Xiao-Song Wu   +5 more
doaj   +1 more source

Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation

open access: yesFrontiers in Genetics, 2021
COVID-19 has posed a significant threat to global health. Early data has revealed that IL-6, a key regulatory cytokine, plays an important role in the cytokine storm of COVID-19.
Arya Zarinsefat   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy